We are live on ! Find out more
RPTP

RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP

Delisted

RPTP was delisted on the 24th of October, 2016.

Back to rankings

0 hedge funds and large institutions have $0 invested in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 111 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 111 → 0 (-111)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $468M → $0 (-$468M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 111

Holders
–
Holders Change
-111
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
111
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
AA
AQR Arbitrage
Connecticut
-$36.4M
2
MF
Magnetar Financial
Illinois
-$35.6M
3
AAM
Alpine Associates Management
Florida
-$34.1M
4
BFA
BlackRock Fund Advisors
California
-$31.4M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$30.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS AM
76
UBS AM
Illinois
– -$374K -41,657 Closed
VOYA Investment Management
77
VOYA Investment Management
Georgia
– -$345 -38,504 Closed
Wells Fargo
78
Wells Fargo
California
– -$273K -30,434 Closed
TI
79
Trexquant Investment
Connecticut
– -$256K -28,587 Closed
Parallax Volatility Advisers
80
Parallax Volatility Advisers
California
– -$240K -26,775 Closed
Capital Fund Management (CFM)
81
Capital Fund Management (CFM)
France
– -$207K -23,090 Closed
Bank of America
82
Bank of America
North Carolina
– -$205K -22,877 Closed
GCP
83
GSA Capital Partners
United Kingdom
– -$199K -22,152 Closed
T. Rowe Price Associates
84
T. Rowe Price Associates
Maryland
– -$159K -17,700 Closed
GAM
85
Gotham Asset Management
New York
– -$150K -16,756 Closed
ST
86
Spot Trading
Illinois
– -$139K -15,452 Closed
Principal Financial Group
87
Principal Financial Group
Iowa
– -$135K -15,051 Closed
BlackRock
88
BlackRock
New York
– -$131K -14,567 Closed
SMC
89
S. Muoio & Co
New York
– -$124K -13,814 Closed
AG
90
Aperio Group
California
– -$112K -12,537 Closed
FMA
91
FNY Managed Accounts
New York
– -$111K -12,423 Closed
PPA
92
Parametric Portfolio Associates
Washington
– -$98K -10,926 Closed
Legal & General Group
93
Legal & General Group
United Kingdom
– -$96K -10,699 Closed
PAM
94
Princeton Alpha Management
New Jersey
– -$94K -10,459 Closed
AIM
95
Alambic Investment Management
California
– -$90K -10,000 Closed
KPF
96
K2 Principal Fund
Ontario, Canada
– -$90K -10,000 Closed
ST
97
Sphinx Trading
Illinois
– -$90K -10,000 Closed
WAM
98
Wolverine Asset Management
Illinois
– -$84K -9,400 Closed
Canada Life
99
Canada Life
Manitoba, Canada
– -$77K -8,609 Closed
AF
100
Allworth Financial
California
– -$70K -7,849 Closed
1 2 3
4
5

RPTP Hedge Fund Activity: Q4 2016 in Review

0 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) for Q4 2016, worth a combined $0 — down 100% from $468M a quarter earlier.

Sellers outnumbered buyers: 111 funds closed out of RPTP and 0 opened new positions — a net loss of 111 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was AQR Arbitrage, exiting entirely with an estimated $36.4M sold.

  • 0 institutional investors held RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) as of Q4 2016, down from 111 in Q3 2016.
  • Funds reported $0 of RAPTOR PHARMACEUTICAL CORP COM STK (DE) stock for Q4 2016, down 100% quarter-over-quarter.
  • 0 funds opened new RAPTOR PHARMACEUTICAL CORP COM STK (DE) positions in Q4 2016 and 111 closed out, a net change of -111 holders.
  • The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) seller in Q4 2016 was AQR Arbitrage, an estimated $36.4M sold.

Based on aggregated 13F filings for Q4 2016.